India’s IVF Boom: Hope, Science, and Business

In frame: Illustrative Visualization of IVF Process

Infertility is an increasingly pressing concern in India, affecting nearly 10–15% of married couples. With an estimated 33–34 million couples actively seeking children but facing infertility challenges, the demand for assisted reproductive technology (ART), including in-vitro fertilization (IVF), has been on the rise.

Understanding IVF and How It Has Evolved Across the World

In-vitro fertilization (IVF) is an assisted reproductive technology (ART) used to treat infertility. It involves retrieving mature eggs from a woman’s ovaries, fertilizing them with sperm in a laboratory, and then implanting the fertilized embryo into the uterus. IVF has enabled millions of couples worldwide to conceive, making it one of the most widely used fertility treatments.

Journey of Innovations in Global IVF

Since its inception, IVF has evolved through groundbreaking scientific advancements, improving success rates and accessibility worldwide. The journey of IVF is marked by key milestones that have shaped modern fertility treatments.

• 1959: Discovery of Sperm Capacitation — M.C. Chang’s research on sperm capacitation provided crucial insights into fertilization, laying the foundation for assisted reproductive technologies like IVF.
• 1969: First Human Oocyte Fertilized In Vitro — Robert Edwards and Patrick Steptoe successfully fertilized a human egg outside the body, proving IVF was possible and revolutionizing infertility treatment.
• 1978: Birth of the First IVF Baby, Louise Brown — Louise Brown’s birth in the UK confirmed IVF as a viable fertility treatment, offering hope to millions of couples worldwide.
• 1978: India’s First IVF Baby, Durga — Dr. Subhash Mukherjee pioneered India’s first IVF success, though his contributions were recognized posthumously due to bureaucratic challenges.
• 1980s: Introduction of Transvaginal Oocyte Retrieval — The adoption of ultrasound-guided egg retrieval made IVF less invasive, improving efficiency and success rates significantly.
• 1992: Introduction of Intracytoplasmic Sperm Injection (ICSI) — ICSI enabled fertilization in severe male infertility cases by directly injecting a sperm into an egg, enhancing IVF success rates.
• 2000s: Advances in Preimplantation Genetic Testing (PGT) — PGT allowed screening embryos for genetic disorders before implantation, improving pregnancy outcomes and reducing hereditary disease risks.
• Present and Future: AI and Gene Editing in IVF — AI is enhancing embryo selection, while gene-editing technologies like CRISPR are being explored for future applications, despite ethical concerns.

These innovations have played a crucial role in making IVF safer, more effective, and more widely available.

Infertility is on the Rise in India Due to Lifestyle and Clinical Factors

Infertility rates in India are steadily increasing, influenced by multiple factors:

1. Lifestyle Changes

• Increasing Marital Age: The average age of marriage in India is rising, particularly in urban areas. Women who delay marriage and childbirth until their late 20s or early 30s face a natural decline in ovarian reserve. Fertility rates are significantly lower in women aged 30–49 compared to those in their 20s. With a shorter reproductive window, many couples struggle to conceive naturally and have to rely on fertility treatments such as IVF.
• Rise in Working Women and Career Prioritization: With more women pursuing higher education and professional careers, family planning is being postponed. This delay in childbearing increases the risk of age-related infertility, irregular ovulation, and hormonal imbalances. Workplace stress, long working hours, and lack of work-life balance further contribute to fertility issues. Exposure to environmental pollutants in certain professions may also impact reproductive health.
• Alcohol and Tobacco Consumption: The increasing prevalence of alcohol and tobacco consumption in India has direct implications for infertility. Tobacco use among Indian men is around 47.9%, one of the highest in the world, while female tobacco consumption is also rising. Smoking affects sperm count and motility in men and reduces egg quality in women. Alcohol consumption can lead to hormonal imbalances, reduced sperm production, and irregular ovulation.
• Obesity and Sedentary Lifestyle: Obesity is emerging as a major cause of infertility in both men and women. India has the third-highest number of obese individuals worldwide, with urban populations particularly affected. A high Body Mass Index (BMI) disrupts hormone levels, leading to ovulatory dysfunction in women and lower sperm quality in men. Metabolic disorders such as insulin resistance further complicate fertility outcomes.

2. Clinical Factors

• Polycystic Ovarian Syndrome (PCOS): PCOS is a leading cause of female infertility in India, affecting between 3.7% to 22.5% of women. It is a hormonal disorder that leads to irregular ovulation, insulin resistance, and an increased risk of miscarriage. Studies indicate that urban adolescent girls in India have a higher prevalence of PCOS (up to 25%) compared to rural areas (11%).
• Endometrial Tuberculosis (TB): Endometrial tuberculosis is a silent yet significant cause of infertility in Indian women. It affects the uterine lining, leading to tubal blockage and implantation failure. Studies estimate that 18% of infertile women in India suffer from endometrial TB, compared to just 1% in the USA. The lack of early diagnosis and treatment makes it a major contributor to female infertility.
• Sexually Transmitted Infections (STIs): STIs such as chlamydia, gonorrhea, and syphilis cause pelvic inflammatory disease (PID) and fallopian tube blockages, leading to infertility in women. In men, STIs can impair sperm production and quality. A large-scale analysis of 41 studies found that 7–34% of Indian men and women suffer from STIs, but awareness and screening remain low.
• Poor Ovarian Reserve in South Asian Women: South Asian women tend to have a lower ovarian reserve compared to Caucasian women, leading to an earlier onset of infertility. A comparative study between Indian and Spanish women found that Indian women had significantly lower Anti-Mullerian Hormone (AMH) levels and a faster decline in antral follicle count (AFC). Even with similar embryo quality, Indian women had lower IVF success rates than Caucasians.

Despite these rising infertility rates, only about 1% of affected couples seek medical treatment, highlighting a significant gap in healthcare awareness and accessibility.

Infertility Problem Can Be Tackled by Raising Awareness and Expanding IVF Access

The problem has two solutions:

1. Increase in awareness about infertility and available treatments
2. Simultaneous expansion of IVF access across India

If both of these progress together at a strong pace, India can not only serve its domestic infertility burden but also emerge as a global hub for fertility treatments, attracting medical tourists from across the world. Fortunately, both awareness and access to treatment are improving significantly in recent years, making infertility care more accessible than ever.

1. Increasing Awareness About Infertility and Treatment Options

• Breaking the Stigma Around Infertility: Infertility in India is often viewed as a social failure rather than a medical condition. Couples delay seeking treatment due to social stigma, misinformation, and emotional distress. Awareness campaigns are crucial to normalize infertility discussions and encourage medical intervention at the right time.
• Educating Couples About Early Diagnosis: Many couples fail to recognize fertility issues until it’s too late. Women in their late 20s and early 30s, especially those with risk factors like PCOS, obesity, or irregular cycles, should proactively monitor their reproductive health. Regular ovarian reserve tests (AMH and AFC) and semen analysis for men can help detect issues early.
• Promoting Medical Consultations Over Myths and Home Remedies: Traditional beliefs and home remedies often delay proper medical intervention. Many couples wait for years before seeking professional help, reducing their chances of success. Encouraging timely fertility assessments and consultations with specialists can significantly improve outcomes.
• Government and Corporate-Led Awareness Programs: National education campaigns on reproductive health should be integrated into school curriculums and corporate wellness programs. Employers should provide infertility support as part of employee healthcare benefits. Government policies should promote fertility awareness in public health programs, similar to maternal health initiatives.

2. Simultaneous Expansion of IVF Access Across India

• Rapid Expansion of IVF Clinics: India has seen a surge in IVF clinics, especially in metropolitan and Tier-1 cities. However, 55% of IVF cycles are still concentrated in just eight metro cities, limiting access for patients in smaller towns. The next wave of fertility care is expected to expand into Tier-2 and Tier-3 cities.
• Growth of Organized Fertility Chains: Traditionally, the infertility treatment market in India was dominated by standalone clinics with varying quality standards. Today, corporate-backed fertility chains are emerging, ensuring better standardization, affordability, and patient care.
• Standardization of IVF Treatments: Many fertility chains are introducing international treatment protocols, ensuring higher success rates. The use of AI-driven embryo selection, genetic screening (PGT), and minimal stimulation IVF is improving outcomes.
• Increase in Affordability and Financing Options: IVF in India costs between ₹1.5–2 lakh per cycle, which is expensive for most Indian couples. Financial solutions like EMI options, insurance coverage, and government subsidies are making IVF more accessible.

Making India a Lucrative IVF Market for Healthcare Stakeholders

Indian IVF presents a unique and massive opportunity for healthcare stakeholders. The market offers substantial potential, both from a domestic demand perspective and in terms of global demand, particularly driven by medical tourism. Let’s explore both opportunities in detail:

1. Domestic Demand and Scale

The domestic demand for IVF in India has witnessed significant growth, driven by various factors such as delayed marriages, rising infertility rates, and increased awareness about assisted reproductive technologies. According to the Indian Society of Assisted Reproduction (ISAR), the IVF industry in India is expected to grow at a compound annual growth rate (CAGR) of 15–20%, highlighting the increasing reliance on IVF treatments to address infertility issues.

With a large population, evolving social norms, and growing middle-class families, the domestic market for IVF is poised for significant growth, creating ample opportunities for healthcare stakeholders to invest, expand, and scale their IVF service offerings.

2. Global Demand and Medical Tourism

India’s IVF sector holds a significant competitive advantage globally, mainly due to its cost-effectiveness compared to other nations. The cost of IVF in India is a fraction of what it is in countries like the US, UK, and Australia, making it an attractive destination for medical tourism. This disparity in treatment costs positions India as a leading player in the global medical tourism market, particularly for IVF procedures.

Source: medicaltourism.com

Key factors driving global demand include:

• Affordable IVF Packages: The cost of IVF in India can be 60–70% lower than in Western countries, making it a compelling choice for international patients.
• High-Quality Healthcare Infrastructure: India boasts world-class fertility clinics with highly trained specialists, state-of-the-art technology, and high success rates, all of which contribute to its attractiveness as a global IVF destination.
• Medical Tourism Growth: As medical tourism in India grows, fertility tourism has emerged as one of its fastest-growing segments. India is not only attracting patients from neighboring countries like Bangladesh and Sri Lanka but also from distant regions like Africa, the Middle East, and even Western countries.

Assessing an IVF Investment Opportunity

Source: Financial Performance Analysis of IVF Clinics

A typical IVF centre of approximately 5,000 sqft with 2 doctors can be established with a capital expenditure ranging from INR 2.5 Crore to INR 4 Crore. The setup costs include medical equipment, clinic infrastructure, staffing, and initial marketing. The potential returns on this investment, however, are highly attractive, with the centre capable of generating significant revenue within a short period.

Key Financial Insights:

Capital Expenditure (CapEx):

• Setup cost for a 5,000 sqft centre: INR 2.5 Crore to INR 4 Crore
• Expenditure covers clinic infrastructure, medical equipment, technology, staffing, and regulatory compliance

Revenue Generation Potential:

• Within 18 months, the centre can generate INR 6 Crore to INR 10 Crore
• This revenue is driven by an average realization of INR 2.5–3 Lakhs per IVF cycle
• With the growing demand for IVF treatments, especially in urban areas, this revenue scale can be achieved relatively quickly

Profitability Margins:

• Gross Margins: Typically range between 60%–75%, reflecting the high value-add nature of IVF treatments
• EBITDA Margins: Typically range between 20%–35% due to the capital-intensive nature of the business in the early stages

Scalability and Growth:

• The IVF centre business is highly scalable, with the potential for rapid expansion. Depending on the pace of opening new centres, a well-managed corporate IVF chain can stabilize and generate 15%–20% EBITDA margins at a steady state
• Achieving economies of scale, reducing per-centre operating costs, and increasing brand recognition will drive profitability in the long run

The IVF centre business, with its potential for high margins and scalability, represents a highly attractive investment opportunity in the healthcare space. With a relatively low initial investment and high revenue generation potential, stakeholders can expect strong returns as new centres achieve scale and profitability.

Strong Returns and High Margins Have Fueled the Rise of New Players and Accelerated Growth of Existing Ones

Source: Tracxn and Press Releases

India’s IVF market is fragmented, with a mix of IVF clinic chains, hospital-based fertility centers, and standalone centres. Some key players include:

1. IVF Clinic Chains

• Indira IVF: Founded in 1988 by Dr. Ajay Murdia, Indira IVF has become India’s largest fertility chain, boasting over 150 centers across 20 states. The clinic is renowned for its advanced reproductive technologies and has successfully assisted over 125,000 couples in achieving parenthood.
• Nova IVF Fertility: As the second-largest IVF network in India, Nova IVF focuses on personalized care and evidence-based treatments. Backed by Asia Healthcare Holdings, it emphasizes innovation and high-quality fertility services across its numerous locations.
• Oasis Fertility: Established in 2009 by Kiran Gadela, Oasis Fertility operates multiple centers throughout India. The chain is committed to ethical fertility care and advanced treatments, prioritizing a patient-first approach in all its services.
• Ferty9 Fertility Center: Founded in 2013 by Dr. C. Jyothi Budi in Telangana, Ferty9 specializes in providing budget-friendly fertility solutions while integrating the latest technologies such as IVF and ICSI. The center aims to make fertility treatments accessible to a broader demographic.
• Crysta IVF: Co-founded in 2018 by Dheeraj Jain, Crysta IVF is part of Redcliffe Lifetech and utilizes AI-driven solutions to enhance fertility services. With a scalable model, it offers comprehensive reproductive care across major Indian cities.
• Genome: A boutique IVF chain under the Ambuja Neotia Group, Genome integrates global fertility protocols with a patient-centric approach. It operates primarily in eastern India, focusing on personalized treatment plans for couples.
• Iswarya Fertility Centre: Established in 1992 and part of K V Textiles Pvt. Ltd., Iswarya has evolved into a leading fertility chain specializing in high-risk cases and donor programs. The center is known for its comprehensive approach to surrogacy and infertility treatments.

Hospital-Based Fertility Centers

• Birla Fertility & IVF: Launched in 2020 as part of the C K Birla Group, Birla Fertility operates 50 centers across 32 cities. It combines advanced fertility care with holistic wellness approaches, offering a range of services including male infertility treatment and fertility preservation.
• Apollo Fertility: Backed by Apollo Hospitals, the largest healthcare network in India, Apollo Fertility provides specialized IVF services across multiple cities. The center integrates hospital-based expertise with advanced reproductive technologies to ensure high-quality care for patients.
• Cloudnine Fertility: As an extension of Cloudnine Hospitals, this fertility center benefits from a strong legacy in maternal and child care. Cloudnine Fertility offers comprehensive reproductive solutions including IVF, IUI, and egg freezing, focusing on personalized patient care.

This Has Made the Space Attractive, Driving Greater Investor Interest

Source: Tracxn and Press Releases

1. Expansion of Capacity and Geographic Reach

• Trend: Players are investing in increasing their capacity, opening new centers, and expanding into tier 2 and 3 cities.
• Reason for Raising Money: To scale operations, serve a wider demographic, and tap into under-served markets with rising demand for fertility treatments.

2. Technology Integration and Digitalization

• Trend: Adoption of advanced technologies like AI for embryo selection, telemedicine for consultations, and patient management systems.
• Reason for Raising Money: To enhance treatment efficiency, improve patient outcomes, and stay competitive in a tech-driven market.

3. Branding and Marketing

• Trend: IVF centers are focusing on brand building and digital marketing strategies to attract patients, especially for high-cost services.
• Reason for Raising Money: To strengthen their brand presence, create awareness, and build trust in a highly competitive market.

4. Clinical Research and Innovation

• Trend: Investment in research for improving treatment success rates, and exploring innovations like egg freezing and genetic testing.
• Reason for Raising Money: To stay at the forefront of clinical excellence, attract more patients, and offer differentiated services that justify premium pricing.

The Next Wave of IVF Expansion Will Happen in Smaller Cities Driven by Untapped Opportunities in Tier 2 and Tier 3 Cities

With the IVF market in Tier-1 cities reaching saturation, the next phase of growth lies in Tier-2 and Tier-3 cities, where infertility rates are rising, awareness is increasing, and access to specialized fertility care remains limited. These regions present a high-growth, first-mover opportunity for IVF expansion, driven by shifting demographics, evolving patient preferences, and an increasing demand for advanced reproductive treatments.

1. Tier-1 Saturation and Limited Growth Potential

• The IVF market in Tier-1 cities is dominated by PE-backed chains, leading to intense competition and pricing pressures.
• High real estate and operational costs make further expansion challenging, limiting ROI for new entrants.
• Patient acquisition costs are rising due to a crowded market, making Tier-1 less attractive for long-term growth.

2. Rising Demand Dynamics in Tier-2 and Tier-3 Cities

• Rising Infertility Rates: Studies indicate infertility prevalence of 15–20% in smaller cities, driven by lifestyle changes, pollution, and delayed pregnancies.
• Shifting Patient Demographics: Earlier, IVF patients were mostly older couples who had exhausted other options; now, younger couples in their late 20s and early 30s are seeking proactive fertility solutions.
• Growing Awareness & Willingness to Pay: Increased education on reproductive health and higher disposable incomes are making IVF a viable option in non-metro regions.
• Limited Competition & Market Gap: Unlike metros, Tier-2 and Tier-3 cities have fewer specialized fertility centers, creating a first-mover advantage for early entrants.

India’s IVF market is experiencing a dynamic transformation, driven by both rising demand and significant advancements in technology. As awareness spreads and IVF access expands into smaller cities, India is well-positioned to become a global leader in fertility care. The combination of a growing domestic market and the influx of international patients seeking affordable, high-quality treatment makes the IVF sector a prime investment opportunity, offering substantial growth potential for stakeholders in healthcare.

LoEstro Advisors is an investment banking firm specializing in sell-side fundraise and M&A advisory, along with a strong consulting arm. Recognized as the #1 financial advisor in education in India, we are the advisor of choice to India’s blue-chip education businesses.

Over the last four years, we have grown to be one of India’s largest (in terms of M&A transactions) homegrown boutique investment banks, with $1.2bn+ worth of combined deals closed across education, healthcare, consumer, and technology sectors.